Evidence map›Paper›PMID 15265232›Full record

ArticleBMC cancer2004

Identification of astrocytoma associated genes including cell surface markers.

Kathy Boon, Jennifer B Edwards, Charles G Eberhart, Gregory J Riggins

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Aquaporins in Nervous System.Advances in experimental medicine and biology · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Collagen VI in healthy and diseased nervous system.Disease models & mechanisms · 2018
    Review
  9. Aquaporins and Brain Tumors.International journal of molecular sciences · 2016
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1.Journal of the American Society of Nephrology : JASN · 2009
    Article
  17. Article
  18. Article
  19. Article
  20. Aquaporins--new players in cancer biology.Journal of molecular medicine (Berlin, Germany) · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kathy BoonDepartment of Neurosurgery, Mason F, Lord Bldg, Center Tower, 5th Floor, 5200 Eastern Avenue, Baltimore MD 21224, USA. cboon1@jhmi.edu
Jennifer B Edwards
Charles G Eberhart
Gregory J Riggins
Johns Hopkins Medicine · USUniversity of Maryland Medical Center · US

Funding

A MOLECULAR CLASSIFICATION OF BRAIN TUMORSU01CA088128 · NCI · JOHNS HOPKINS UNIVERSITY · PI RIGGINS, GREGORY JOSEPH · 2000 to 2004
$2.9M
NCI NIH HHS U01 CA088128NCI NIH HHS U01 CA88128
6 · The paper itself

Abstract

backgroundDespite intense effort the treatment options for the invasive astrocytic tumors are still limited to surgery and radiation therapy, with chemotherapy showing little or no increase in survival. The generation of Serial Analysis of Gene Expression (SAGE) profiles is expected to aid in the identification of astrocytoma-associated genes and highly expressed cell surface genes as molecular therapeutic targets. SAGE tag counts can be easily added to public expression databases and quickly disseminated to research efforts worldwide.

methodsWe generated and analyzed the SAGE transcription profiles of 25 primary grade II, III and IV astrocytomas 1. These profiles were produced as part of the Cancer Genome Anatomy Project's SAGE Genie 2, and were used in an in silico search for candidate therapeutic targets by comparing astrocytoma to normal brain transcription. Real-time PCR and immunohistochemistry were used for the validation of selected candidate target genes in 2 independent sets of primary tumors.

resultsA restricted set of tumor-associated genes was identified for each grade that included genes not previously associated with astrocytomas (e.g. VCAM1, SMOC1, and thymidylate synthetase), with a high percentage of cell surface genes. Two genes with available antibodies, Aquaporin 1 and Topoisomerase 2A, showed protein expression consistent with transcript level predictions.

conclusionsThis survey of transcription in malignant and normal brain tissues reveals a small subset of human genes that are activated in malignant astrocytomas. In addition to providing insights into pathway biology, we have revealed and quantified expression for a significant portion of cell surface and extra-cellular astrocytoma genes.

Indexed as

Gene Expression Regulation, NeoplasticAdultAstrocytomaBase SequenceBiomarkers, TumorBrain NeoplasmsChildExtracellular MatrixHumansImmunohistochemistryMembrane ProteinsBiomarkers, TumorMembrane Proteins

Identifiers

PMID15265232
PMCPMC497045
OpenAlexW1793647354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.